[ad_1]
SAN DIEGO, April 23, 2022 /PRNewswire/ — The law firm of Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) securities between May 7, 2021 and February 25, 2022both dates inclusive (the “Class Period”) have until June 14, 2022 to seek appointment as lead plaintiff in Ortmann v. Aurinia Pharmaceuticals Inc.No. 22-cv-02185 (EDNY). Commenced on April 15, 2022the Aurinia class action lawsuit charges Aurinia and certain of its top executive officers with violations of the Securities Exchange Act of 1934.
![]("https://mma.prnewswire.com/media/198876/robbins_geller_rudman_and_dowd_llp_logo.jpg" "\"Robbins"){kind=logo}
http://www.rgrdlaw.com for more information. (PRNewsFoto/Robbins Geller Rudman & Dowd LLP)” alt=”Robbins Geller, with 200 lawyers in ten offices, represents US and international institutional investors in contingency-based securities and corporate litigation. The firm has obtained many of the largest securities class action recoveries in history, including the largest securities class action judgment. Please visit http://www.rgrdlaw.com for more information. (PRNewsFoto/Robbins Geller Rudman & Dowd…
Full story available on Benzinga.com
[ad_2]
Source link
